Condition: Advanced Solid Tumor Cancer · Primary CNS Tumors · Sponsor: The Belgian Society of Medical Oncology
A total of 550 patients with metastatic solid tumors or primary CNS malignancy will be recruited on a first come first serve basis at one of the 14 participating centers : UZL, UZG, Imelda, ZAZ, AZ Klina, CHU Liège, GHdC, CHU UCL Namur, IJB, UZB, CUSL, UZA, VITAZ and Jessa Zh.. \> 500 patients with tissue available will undergo CGP centrally at UZ Leuven (Roche AVENIO Tumor Tissue CGP kits, Novaseq platform). \> 50 patients without tissue available will undergo liquid biopsy testing at Foundation Medicine (FoundationOne Liquid CDx). The sequencing data generated by UZ Leuven laboratory will then be further analysed (secondary and tertiary analysis) by one of the eight laboratories participating in the study: UZL, UZG, IJB, CUSL, IPG, UZA, Jessa zh. and CHU Liège.
This description comes directly from the study's public registry record.
Julie Maetens · +32 2 642 54 90 · Julie.Maetens@sciensano.be
Gordana RaicevicToungouz · +32 2 642 54 90 · Gordana.RaicevicToungouz@sciensano.be
Always discuss trial participation with your own doctor first.
| Institute Jules Bordet | Anderlecht, Belgium | Recruiting |
| ZAS | Antwerp, Belgium | Recruiting |
| Imelda | Bonheiden, Belgium | Recruiting |
| AZ Klina | Brasschaat, Belgium | Recruiting |
| Universitaire Ziekenhuis Antwerpen | Edegem, Belgium | Recruiting |
| UZ Gent | Ghent, Belgium | Recruiting |
| GHDC | Gilly, Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt, Belgium | Recruiting |
| UZ Brussel | Jette, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| CHU Liège Sart Tilman | Liège, Belgium | Recruiting |
| CHU UCL Namur | Namur, Belgium | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07713550